skip to Main Content

Towards an Optimal Treatment Algorithm for Metastatic Pancreatic Ductal Adenocarcinoma (PDA)

Towards an Optimal Treatment Algorithm for Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Pancreatic ductal adenocarcinoma (pda) is a challenging disease and the fourth leading cause of cancer death worldwide. It has a poor prognosis, with less than 2% of patients surviving more than five years.

More than 80% of subjects are diagnosed with metastatic or unresectable disease and are mainly treated with palliative chemotherapy for symptom control and survival prolongation. Read more . . .


Back To Top